Respiratory imaging technology company 4DMedical Limited has officially inked agreements to provide XV LVAS scans at imaging facilities within the Detroit and Memphis communities.
The announcement follows last week’s revelation that the US Centres for Medicare & Medicaid Services (CMS) has granted approval for reimbursement of 4DMedical’s XV LVAS scans.
The approved reimbursement rate stands at USD 299 (AUD 456) per procedure, and it is set to take effect from 1 January 2024.
The breakthrough announcement comes as PrecisionIR, a leading radiology practice in Detroit, Michigan, and Memphis Vascular Centre in Tennessee, have both signed Software as a Service (SaaS) agreements with 4DMedical to offer XV LVAS scans in their outpatient clinics.
According to the ASX-listed company, the move is expected to enhance patient and referrer access to cutting-edge respiratory diagnostics in a more convenient and patient-centric environment.
Dr S. Andrew Vartanian, board-certified Interventional Radiologist and Medical Director of PrecisionIR, expressed excitement about offering XV LVAS scans to the Detroit community.
“4DMedical’s XV Technology enables physicians to understand regional airflow in the lungs and identify respiratory deficiencies as they breathe,” Dr Vartanian noted.
He also highlighted the non-invasive nature of the test, its quick duration (approximately 5 minutes), and the absence of potentially harmful contrast agents.
“Providing 4DMedical technology to our patients beginning in January is exciting, but equally is the opportunity to scan the veteran community in need of answers,” Dr Vartanian noted.
4DMedical’s Founder and CEO Andreas Fouras underscored the significance of access to reimbursement and its impact on the speed of market uptake.
He stated, “I am thrilled to see imaging facilities being brought online to serve patients in the communities of Detroit and Memphis.”
“Not all patients needing scans want to visit a hospital environment for a lung assessment, and we are pleased to grow these options in the U.S., in parallel with expanding our traditional hospital providers,” Fouras added.